AJ91 Stock Overview
Offers marketing and e-commerce services for the healthcare sector in Europe. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
My Notes
Capture your thoughts, links and company narrative
DocCheck AG Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €8.00 |
| 52 Week High | €9.50 |
| 52 Week Low | €7.00 |
| Beta | 0.64 |
| 1 Month Change | -4.19% |
| 3 Month Change | 5.96% |
| 1 Year Change | -15.34% |
| 3 Year Change | -73.15% |
| 5 Year Change | -13.98% |
| Change since IPO | -71.10% |
Recent News & Updates
DocCheck's (ETR:AJ91) Returns On Capital Not Reflecting Well On The Business
Nov 19
We Think You Can Look Beyond DocCheck's (ETR:AJ91) Lackluster Earnings
Apr 19Recent updates
DocCheck's (ETR:AJ91) Returns On Capital Not Reflecting Well On The Business
Nov 19We Think You Can Look Beyond DocCheck's (ETR:AJ91) Lackluster Earnings
Apr 19DocCheck (ETR:AJ91) Has Some Way To Go To Become A Multi-Bagger
Aug 04Estimating The Fair Value Of DocCheck AG (ETR:AJ91)
May 20The Trend Of High Returns At DocCheck (ETR:AJ91) Has Us Very Interested
Nov 06Returns On Capital Are A Standout For DocCheck (ETR:AJ91)
Mar 03If You Like EPS Growth Then Check Out DocCheck (ETR:AJ91) Before It's Too Late
Jan 18Do DocCheck's (ETR:AJ91) Earnings Warrant Your Attention?
Aug 26Should DocCheck AG (ETR:AJ91) Be Part Of Your Dividend Portfolio?
May 02Investors Shouldn't Overlook DocCheck's (ETR:AJ91) Impressive Returns On Capital
Apr 18Should You Be Adding DocCheck (ETR:AJ91) To Your Watchlist Today?
Mar 23Is DocCheck AG's (ETR:AJ91) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?
Mar 04Did You Participate In Any Of DocCheck's (ETR:AJ91) Incredible 419% Return?
Feb 14Could The DocCheck AG (ETR:AJ91) Ownership Structure Tell Us Something Useful?
Jan 27Under The Bonnet, DocCheck's (ETR:AJ91) Returns Look Impressive
Jan 10If You Like EPS Growth Then Check Out DocCheck (ETR:AJ91) Before It's Too Late
Dec 22What Can We Conclude About DocCheck's (ETR:AJ91) CEO Pay?
Dec 07
DocCheck AG's (ETR:AJ91) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?
Nov 22Shareholder Returns
| AJ91 | DE Healthcare Services | DE Market | |
|---|---|---|---|
| 7D | 0.6% | -0.3% | -1.4% |
| 1Y | -15.3% | -19.5% | 8.0% |
Return vs Industry: AJ91 exceeded the German Healthcare Services industry which returned -20.2% over the past year.
Return vs Market: AJ91 underperformed the German Market which returned 8.1% over the past year.
Price Volatility
| AJ91 volatility | |
|---|---|
| AJ91 Average Weekly Movement | 5.1% |
| Healthcare Services Industry Average Movement | 5.8% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 11.9% |
| 10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: AJ91 has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: AJ91's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | 433 | Frank Antwerpes | www.doccheck.ag |
DocCheck AG offers marketing and e-commerce services for the healthcare sector in Europe. The company operates DocCheck portal for exchanging information on the Internet, as well as involved in online advertising, market research, and studies for healthcare market players. It also develops and implements communication strategies for media on healthcare and business-to-business sectors.
DocCheck AG Fundamentals Summary
| AJ91 fundamental statistics | |
|---|---|
| Market cap | €40.59m |
| Earnings (TTM) | €2.45m |
| Revenue (TTM) | €51.64m |
16.6x
P/E Ratio0.8x
P/S RatioIs AJ91 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| AJ91 income statement (TTM) | |
|---|---|
| Revenue | €51.64m |
| Cost of Revenue | €39.04m |
| Gross Profit | €12.60m |
| Other Expenses | €10.15m |
| Earnings | €2.45m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.48 |
| Gross Margin | 24.40% |
| Net Profit Margin | 4.74% |
| Debt/Equity Ratio | 0% |
How did AJ91 perform over the long term?
See historical performance and comparisonDividends
6.3%
Current Dividend Yield104%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/18 07:37 |
| End of Day Share Price | 2024/12/18 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
DocCheck AG is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|